NCT03639194 A Study of ABBV-011 Alone and in Combination With Budigalimab (ABBV-181) in Participants With Relapsed or Refractory Small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT03637517 Malaria: Relative Bioavailability and Food Effect of DSM265 Status COMPLETED Phase PHASE1
NCT03625505 A Study to Assess Safety and Efficacy of Venetoclax in Combination With Gilteritinib in Participants With Relapsed/Refractory Acute Myeloid Leukemia Status COMPLETED Phase PHASE1
NCT03625037 First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03607422 A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2) Status COMPLETED Phase PHASE3
NCT03595059 A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors Status COMPLETED Phase PHASE1
NCT03593213 Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Participants With Schizophrenia Status TERMINATED Phase PHASE3
NCT03573297 A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features Status COMPLETED Phase PHASE3
NCT03573024 Venetoclax and Azacitidine for Non-Elderly Adult Patients With Acute Myeloid Leukemia Status COMPLETED Phase PHASE2
NCT03569293 Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema) Status COMPLETED Phase PHASE3
NCT03568318 A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03567876 Rituximab, Bendamustine and Cytarabine Followed by Venetoclax in High Risk Elderly Patients With MCL Status COMPLETED Phase PHASE2
NCT03567616 A Study of Venetoclax in Combination With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma Status TERMINATED Phase PHASE2
NCT03557619 A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies Status RECRUITING Phase PHASE1
NCT03549416 BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients with Atopic Dermatitis Status RECRUITING Phase N/A
NCT03539744 A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma. Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03539536 Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03518047 Risankizumab Therapy Versus Placebo for Subjects With Psoriasis in the Russian Federation Status COMPLETED Phase PHASE3